Loading
NT
Neural Therapeutics Inc. Stock: price and insider trades · Canada
Neural Therapeutics Inc.: what insiders have been doing
We have very little insider data for Neural Therapeutics Inc. so far: the most recent filing dates from 17 April 2026. With so few records, no pattern can be drawn yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 17 April 2026
Declarations15 total
500,000 sharesCommon SharesTSXSEDI:4706169
313,929 shares@ CA$0.05100.0% of flowCommon SharesTSXSEDI:4561033
5,415,324 shares100.0% of flowCommon SharesTSXSEDI:4475412
6,606,750 shares100.0% of flowCommon SharesTSXSEDI:4475386
833,333 shares@ CA$0.0351.0% of flowCommon SharesTSXSEDI:4474835
8,858,881 shares@ CA$0.002748.8% of flowCommon SharesTSXSEDI:4474836
4,044 shares@ CA$0.030.3% of flowCommon SharesTSXSEDI:4469611
Common SharesTSXSEDI:4443507
Common SharesTSXSEDI:4443220
Common SharesTSXSEDI:4442906
Common SharesTSXSEDI:4425131
Common SharesTSXSEDI:4424510
2,250,000 shares@ CA$0.0399.1% of flowCommon SharesTSXSEDI:4189913
Common SharesTSXSEDI:4134631
Common SharesTSXSEDI:4134629
15 of 15 declarations
About Neural Therapeutics Inc.
Neural Therapeutics Inc. is a company focused on developing innovative treatments for neurological disorders. It is listed on the XTSE market.
